AmerisourceBergen (ABC) Earning Somewhat Positive News Coverage, Accern Reports

Press coverage about AmerisourceBergen (NYSE:ABC) has trended somewhat positive on Wednesday, Accern reports. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. AmerisourceBergen earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 45.2930505017108 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

These are some of the media headlines that may have effected Accern Sentiment Analysis’s analysis:

Shares of AmerisourceBergen stock traded up $1.29 on Wednesday, hitting $91.43. 715,630 shares of the company traded hands, compared to its average volume of 1,963,207. The stock has a market cap of $19,932.77, a P/E ratio of 15.55, a PEG ratio of 1.37 and a beta of 1.06. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.95 and a quick ratio of 0.50. AmerisourceBergen has a 52 week low of $71.90 and a 52 week high of $106.27.

AmerisourceBergen (NYSE:ABC) last released its quarterly earnings data on Tuesday, February 6th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.35 by $0.20. The firm had revenue of $40.47 billion for the quarter, compared to analysts’ expectations of $40.42 billion. AmerisourceBergen had a net margin of 0.66% and a return on equity of 53.65%. The company’s revenue for the quarter was up 6.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.36 earnings per share. equities analysts expect that AmerisourceBergen will post 6.54 EPS for the current year.

ABC has been the topic of a number of research reports. Leerink Swann set a $105.00 price objective on shares of AmerisourceBergen and gave the stock a “buy” rating in a report on Tuesday, January 2nd. Zacks Investment Research raised shares of AmerisourceBergen from a “hold” rating to a “buy” rating and set a $105.00 price objective on the stock in a report on Wednesday, January 3rd. Evercore ISI initiated coverage on shares of AmerisourceBergen in a report on Thursday, January 4th. They issued an “outperform” rating and a $105.00 price objective on the stock. Needham & Company LLC raised their price objective on shares of AmerisourceBergen from $88.00 to $108.00 and gave the stock a “buy” rating in a report on Tuesday, January 23rd. Finally, Mizuho set a $100.00 price objective on shares of AmerisourceBergen and gave the stock a “hold” rating in a report on Wednesday, January 24th. Two analysts have rated the stock with a sell rating, six have given a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $102.72.

In other AmerisourceBergen news, insider Dale Danilewitz sold 21,500 shares of AmerisourceBergen stock in a transaction on Friday, February 16th. The shares were sold at an average price of $97.30, for a total transaction of $2,091,950.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John G. Chou sold 15,939 shares of AmerisourceBergen stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $97.74, for a total transaction of $1,557,877.86. Following the transaction, the insider now directly owns 67,228 shares of the company’s stock, valued at $6,570,864.72. The disclosure for this sale can be found here. In the last quarter, insiders have sold 155,809 shares of company stock worth $14,536,032. Company insiders own 27.30% of the company’s stock.

TRADEMARK VIOLATION WARNING: This story was posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at https://www.tickerreport.com/banking-finance/3389418/amerisourcebergen-abc-earning-somewhat-positive-news-coverage-accern-reports.html.

About AmerisourceBergen

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

Insider Buying and Selling by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Markel Co.  Vice Chairman Steven A. Markel Sells 200 Shares
Markel Co. Vice Chairman Steven A. Markel Sells 200 Shares
Bottomline Technologies, Inc.  Director Peter Gibson Purchases 4,000 Shares
Bottomline Technologies, Inc. Director Peter Gibson Purchases 4,000 Shares
Old Dominion Freight Line  Director Leo H. Suggs Sells 800 Shares of Stock
Old Dominion Freight Line Director Leo H. Suggs Sells 800 Shares of Stock
Cara Therapeutics  SVP Frederique Ph.D. Menzaghi Sells 9,000 Shares
Cara Therapeutics SVP Frederique Ph.D. Menzaghi Sells 9,000 Shares
Analysts Set Nexeo Solutions  Price Target at $11.17
Analysts Set Nexeo Solutions Price Target at $11.17
Hologic, Inc.  Given Average Recommendation of “Hold” by Analysts
Hologic, Inc. Given Average Recommendation of “Hold” by Analysts


© 2006-2018 Ticker Report. Google+.